{"title":"有或无哮喘史的COPD患者的COPD急性加重和肺癌风险","authors":"Ane Aamli Gagnat, Miriam Gjerdevik, Stein Atle Lie, Amund Gulsvik, Per Bakke, Rune Nielsen","doi":"10.1080/20018525.2020.1799540","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>There is limited knowledge on the effect of acute exacerbations in chronic obstructive pulmonary disease (AECOPD) on lung cancer risk in COPD patients with and without a history of asthma. This study aims to examine whether AECOPD is associated with risk of lung cancer, and whether the effect depends on a history of asthma.</p><p><strong>Methods: </strong>In the GenKOLS study of 2003-2005, 852 subjects with COPD performed spirometry, and filled out questionnaires on smoking habits, symptoms and disease history. These data were linked to lung cancer data from the Cancer Registry of Norway through 2013. AECOPD, measured at baseline was the main predictor. To quantify differences in lung cancer risk, we performed Cox-proportional hazards regression. We adjusted for sex, age, smoking variables, body mass index, and lung function.</p><p><strong>Measurements and results: </strong>During follow-up, 8.8% of the subjects with, and 5.9% of the subjects without exacerbations were diagnosed with lung cancer. Cox regression showed a significant increased risk of lung cancer with one or more exacerbations in COPD patients without a history of asthma, HRR = 2.77 (95% CI 1.39-5.52). We found a significant interaction between a history of asthma and AECOPD on lung cancer.</p><p><strong>Conclusions: </strong>AECOPD is associated with an increased risk of lung cancer in COPD patients without a history of asthma.</p>","PeriodicalId":11872,"journal":{"name":"European Clinical Respiratory Journal","volume":"7 1","pages":"1799540"},"PeriodicalIF":1.8000,"publicationDate":"2020-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/20018525.2020.1799540","citationCount":"2","resultStr":"{\"title\":\"Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma.\",\"authors\":\"Ane Aamli Gagnat, Miriam Gjerdevik, Stein Atle Lie, Amund Gulsvik, Per Bakke, Rune Nielsen\",\"doi\":\"10.1080/20018525.2020.1799540\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale: </strong>There is limited knowledge on the effect of acute exacerbations in chronic obstructive pulmonary disease (AECOPD) on lung cancer risk in COPD patients with and without a history of asthma. This study aims to examine whether AECOPD is associated with risk of lung cancer, and whether the effect depends on a history of asthma.</p><p><strong>Methods: </strong>In the GenKOLS study of 2003-2005, 852 subjects with COPD performed spirometry, and filled out questionnaires on smoking habits, symptoms and disease history. These data were linked to lung cancer data from the Cancer Registry of Norway through 2013. AECOPD, measured at baseline was the main predictor. To quantify differences in lung cancer risk, we performed Cox-proportional hazards regression. We adjusted for sex, age, smoking variables, body mass index, and lung function.</p><p><strong>Measurements and results: </strong>During follow-up, 8.8% of the subjects with, and 5.9% of the subjects without exacerbations were diagnosed with lung cancer. Cox regression showed a significant increased risk of lung cancer with one or more exacerbations in COPD patients without a history of asthma, HRR = 2.77 (95% CI 1.39-5.52). We found a significant interaction between a history of asthma and AECOPD on lung cancer.</p><p><strong>Conclusions: </strong>AECOPD is associated with an increased risk of lung cancer in COPD patients without a history of asthma.</p>\",\"PeriodicalId\":11872,\"journal\":{\"name\":\"European Clinical Respiratory Journal\",\"volume\":\"7 1\",\"pages\":\"1799540\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2020-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/20018525.2020.1799540\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Clinical Respiratory Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/20018525.2020.1799540\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Clinical Respiratory Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20018525.2020.1799540","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 2
摘要
理由:关于慢性阻塞性肺疾病(AECOPD)急性加重对有或无哮喘病史的COPD患者肺癌风险的影响的知识有限。本研究旨在研究AECOPD是否与肺癌风险相关,以及这种影响是否取决于哮喘史。方法:在2003-2005年的GenKOLS研究中,852例COPD患者进行肺活量测定,并填写吸烟习惯、症状和病史问卷。这些数据与2013年挪威癌症登记处的肺癌数据相关联。基线AECOPD是主要预测指标。为了量化肺癌风险的差异,我们进行了Cox-proportional hazards regression。我们调整了性别、年龄、吸烟变量、体重指数和肺功能。测量和结果:随访期间,8.8%有加重的受试者和5.9%无加重的受试者被诊断为肺癌。Cox回归分析显示,无哮喘病史的COPD患者伴一次或多次急性发作的肺癌风险显著增加,HRR = 2.77 (95% CI 1.39-5.52)。我们发现哮喘病史和AECOPD对肺癌有显著的相互作用。结论:无哮喘病史的COPD患者AECOPD与肺癌风险增加相关。
Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma.
Rationale: There is limited knowledge on the effect of acute exacerbations in chronic obstructive pulmonary disease (AECOPD) on lung cancer risk in COPD patients with and without a history of asthma. This study aims to examine whether AECOPD is associated with risk of lung cancer, and whether the effect depends on a history of asthma.
Methods: In the GenKOLS study of 2003-2005, 852 subjects with COPD performed spirometry, and filled out questionnaires on smoking habits, symptoms and disease history. These data were linked to lung cancer data from the Cancer Registry of Norway through 2013. AECOPD, measured at baseline was the main predictor. To quantify differences in lung cancer risk, we performed Cox-proportional hazards regression. We adjusted for sex, age, smoking variables, body mass index, and lung function.
Measurements and results: During follow-up, 8.8% of the subjects with, and 5.9% of the subjects without exacerbations were diagnosed with lung cancer. Cox regression showed a significant increased risk of lung cancer with one or more exacerbations in COPD patients without a history of asthma, HRR = 2.77 (95% CI 1.39-5.52). We found a significant interaction between a history of asthma and AECOPD on lung cancer.
Conclusions: AECOPD is associated with an increased risk of lung cancer in COPD patients without a history of asthma.